Location History:
- Yongin-si, KR (2013)
- Guri-si, KR (2018)
- Gyeonggi-do, KR (2006 - 2019)
Company Filing History:
2 out of 131,744 
1 out of 15 
1 out of 1,115 
Years Active: 2006-2019
Title: Innovator in Hematology: The Contributions of Eun-Mi Lee
Introduction: Eun-Mi Lee, an accomplished inventor from Gyeonggi-do, South Korea, has made significant strides in the field of hematology through her innovative research and patented inventions. With a total of four patents to her name, Lee continues to impact the medical community with her groundbreaking methods and applications.
Latest Patents: Eun-Mi Lee's latest contributions include two notable inventions. The first is a method for the in vitro expansion of erythroid cells, which involves utilizing a three-dimensional packed cell culture system aided by a porous structure. This innovative approach facilitates a more efficient expansion of erythroid cells, crucial for various medical applications. Her second patent pertains to the diagnosis of hematologic diseases, providing a method to screen risk groups. By measuring the levels of gelsolin mRNA in the buffy coat of peripheral blood or bone marrow aspirates, this invention allows for accurate and easy analysis of hematologic disease prognosis, enhancing patient care and treatment strategies.
Career Highlights: Throughout her career, Eun-Mi Lee has held positions at prominent organizations, including Samsung Electronics Co., Ltd. and Iucf-hyu. These experiences have equipped her with a robust foundation in both technology and research, enabling her to develop groundbreaking innovations in her field.
Collaborations: Eun-Mi Lee’s work has been further enriched through collaborations with esteemed colleagues, including Eun Jung Baek and Doo-Hoon Goo. Their collective expertise and insights have played a critical role in advancing her research endeavors and patent developments.
Conclusion: Eun-Mi Lee exemplifies the spirit of innovation in the realm of hematology. Her patented methods for the expansion of erythroid cells and the diagnosis of hematologic diseases highlight her commitment to improving medical outcomes. Through her continuous efforts and collaborations, Lee is poised to lead significant advancements in the field, benefiting patients and healthcare professionals alike.